Could 'open innovation' models that have proved successful in other sectors be fruitfully adopted by the pharmaceutical industry? In the past, the business model adopted by most high-tech ...
According to IMS Health, in 2009 the pharmaceutical market in China increased by 27.9% to reach $31.7 billion and by 2013 — partly because of the effects of both health-care and drug safety ...
Rebecca Aris spoke with Carly Kuper of CMI/Compas to hear her thoughts on how well pharma is currently driving innovation. How well is pharma currently driving innovation and how is it currently ...
The quest for innovation is a major driving force ... 2016’s ‘Learning from successes and failures in pharmaceutical R&D’ in the Journal of Evolutionary Economics have clearly demonstrated ...
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 ...
Patrick Couvreur speaks to Hannah Stanwix, Managing Comissioning Editor: Professor Patrick Couvreur received his pharmacy degree from the Université Catholique de Louvain (Louvain-la-Neuve ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果